Surgery Partners, Inc. (SGRY) FY2026 Q2 P&L / Income Statement

Surgery Partners, Inc. (SGRY) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

848,900,000 US dollars

Total operating expenses

746,800,000 US dollars

Operating income

102,100,000 US dollars

Other income (expense), net (calculated)

negative 69,800,000 US dollars

Income (loss) before income taxes

32,300,000 US dollars

Income tax (expense) benefit

2,600,000 US dollars

Net income (loss)

29,700,000 US dollars

Private insurance

401,400,000 US dollars

Government

380,600,000 US dollars

Self-pay

23,500,000 US dollars

Other

20,600,000 US dollars

Other service revenues

22,800,000 US dollars

Net (gain) loss on disposals, consolidations and deconsolidations

2,400,000 US dollars

Salaries and benefits

253,100,000 US dollars

Supplies

226,800,000 US dollars

Professional and medical fees

102,800,000 US dollars

Other operating expenses

51,800,000 US dollars

Lease expense

24,200,000 US dollars

Transaction and integration costs

18,400,000 US dollars

Litigation settlements

0 US dollars

General and administrative expenses

36,300,000 US dollars

Other income, net

negative 1,900,000 US dollars

Depreciation and amortization

39,300,000 US dollars

Equity in earnings of unconsolidated affiliates

negative 6,400,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Surgery Partners, Inc.: −$15.00 M; to noncontrolling interests: $44.70 M.